Patients diagnosed with new atrial fibrillation after ischemic stroke were more likely to have preexisting cardiovascular comorbidities such as hypertension, heart failure, and coronary artery disease.
Stroke/systemic embolism rates were comparable between patients with atrial fibrillation with or without heart failure.
The hazard ratio for cancer associated with heart failure was 2.16 and was 1.71, after adjustments.
A meta-analysis suggests lowering blood pressure below current guidelines (140 mm Hg) reduces risk of cardiovascular disease events, regardless of comorbidities or baseline blood pressure.
The American College of Cardiology released a decision pathway addressing 10 pivotal issues in heart failure with reduced ejection fraction.
The annual risk of sudden cardiac death/ventricular arrhythmias was higher in patients with atrial fibrillation vs patients without atrial fibrillation.
Technical success was achieved in 46 patients, according to Mitral Valve Academic Research Consortium criteria.
Although current guidelines recommend delaying noncardiac surgery for 6 to 12 months after drug-eluting stent implantation, new data suggest surgery may be performed earlier.
Drug-eluting stents in percutaneous coronary intervention appear to be safer in patients with end-stage renal disease compared with bare-metal stents.
ACC 2017 Meeting Highlights
Atrial fibrillation was associated with a higher risk of adjusted in-hospital mortality and bleeding complications after both PCI and CABG.